AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Blanke, CD Haller, DG Benson, AB Rothenberg, ML Berlin, J Mori, M Hsieh, YC Miller, LL
Citation: Cd. Blanke et al., A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma, ANN ONCOL, 12(11), 2001, pp. 1575-1580

Authors: Blanke, CD Stipanov, M Morrow, J Rothenberg, M Chinery, R Shyr, Y Coffey, R Johnson, DH Leach, SD Beauchamp, RD
Citation: Cd. Blanke et al., A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies, INV NEW DR, 19(1), 2001, pp. 21-27

Authors: Blanke, CD Hemmer, PA Witte, RS
Citation: Cd. Blanke et al., Acute tumor lysis syndrome with choriocarcinoma, SOUTH MED J, 93(9), 2000, pp. 916-919

Authors: John, W Picus, J Blanke, CD Clark, JW Schulman, LN Rowinsky, EK Thornton, DE Loehrer, PJ
Citation: W. John et al., Activity of multitargeted antifolate (Pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma - Results from a phase II study, CANCER, 88(8), 2000, pp. 1807-1813

Authors: Scoggins, CR Meszoely, IM Blanke, CD Beauchamp, RD Leach, SD
Citation: Cr. Scoggins et al., Nonoperative management of primary colorectal cancer in patients with stage IV disease, ANN SURG O, 6(7), 1999, pp. 651-657

Authors: Blanke, CD Choy, H Teng, M Beauchamp, RD Leach, S Roberts, J Washington, K Johnson, DH
Citation: Cd. Blanke et al., Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer, SEM RAD ONC, 9(2), 1999, pp. 43-52

Authors: Blanke, CD Teng, M Choy, H
Citation: Cd. Blanke et al., The role of UFT in combined-modality therapy, ONCOLOGY-NY, 13(10), 1999, pp. 47-54

Authors: Rothenberg, ML Blanke, CD
Citation: Ml. Rothenberg et Cd. Blanke, Topoisomerase I inhibitors in the treatment of colorectal cancer, SEMIN ONCOL, 26(6), 1999, pp. 632-639

Authors: Rose, DM Chapman, WC Brockenbrough, AT Wright, JK Rose, AT Meranze, S Mazer, M Blair, T Blanke, CD Debelak, JP Pinson, CW
Citation: Dm. Rose et al., Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma, AM J SURG, 177(5), 1999, pp. 405-410
Risultati: 1-9 |